Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0043320110340111887
Archives of Pharmacal Research
2011 Volume.34 No. 11 p.1887 ~ p.1897
Designing micro- and nano-particles for treating rheumatoid arthritis
Mitragotri Samir

Yoo Jin-Wook
Abstract
Rheumatoid arthritis (RA) is a chronic, destructive autoimmune disease that can cause disability and have a negative socioeconomic impact. Despite significant advances in therapeutic options, limitations on the routes of administration and the requirement for frequent and long-term dosing often lead to systemic adverse effects and patient non-compliance. Micro and nanoparticle systems that selectively deliver drugs to inflamed synovium have the potential to improve drug efficacy while leaving extrasynovial tissues unaffected. This review summarizes key design parameters of RA-targeted drug carriers and discusses design considerations for improving RA therapies.
KEYWORD
Rheumatoid arthritis, Drug carriers, Microparticles, Nanoparticles, Targeted drug delivery, Size, Surface chemistry, Shape
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI)